PRKN and Parkinson disease: When considering the specific variants under investigation in RbG2 (PRKN variants in heterozygosity, which could slightly increase the risk of some attenuated PD clinical symptoms but with very low penetrance), most participants were willing to know the individual carrier status and they perceived this awareness to be beneficial due to potential passing on to their children and potential onset of symptoms considerations (Step 1).